Korea has already entered into an aging society. In recent decades, the health problems for seniors has received considerable interest. We often see the elderly who have been struggled from discomfort or illness of the foot. Those foot related problems mainly cause from the use of improper shoes. Recently, shoe makers sell the shoes for seniors, so called comfort shoes, but the shoes are too expensive for seniors to buy easily. In this paper, we develop cheap insoles for seniors as an alternative of the comfort shoes and suggest the systematic process for the insoles development. This systematic process is as follows: 1) Survey the literature about the market of insole, 2) Investigate the standard size of body and foot for the seniors in Korea, 3) Analyze the customer needs by survey, 4) Study the walking pattern by experiments, and 5) Develop the novel insole for the seniors to relieve the inconveniences related with foot. From the newly developed insoles, the company B gains the sales increasing effect approximately 30% over through the increase in consumer satisfaction and company reputation and secures for intellectual property rights. Using the database from Korea Research Institute of Standards and Science, the reliability of developing technology of the functional insole has been obtained. The seniors are also enable to choose an alternative of comfort shoes for foot health. In the future, the insoles developed from this study have wide applications in the medical, cosmetic fields, and leisure sports fields. Accordingly, it seems to require more systematic studies utilizing Walk Analyzer and Foot Pressure Meter.

Neuromedin B (NMB) acts as a growth factor or a morphogen and plays a role in cancer progression. Indeed, the NMB receptor (NMB-R) is overexpressed in different types of tumors. In our current study, we investigated the involvement of NMB-R in the proliferation of oral cancer cells. Human oral squamous cell carcinoma (SCC) and human oral cancer cells, SCC-25 cells were found to be NMB-R-positive. The NMB-R antagonist PD168368 inhibited the proliferation of SCC-25 cells and reduced their colony formation capacity. We also found that PD168368 induced the cell cycle arrest and apoptosis of SCC-25 cells in a dose-/time-dependent manner. Overall, this antitumor activity of PD168368 in human oral cancer cells suggests that NMB-R is a potential target for the future prevention and treatment of human cancers.